Willingdon Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$2K	Sell	20 -4	-17%	-$354	﹤0.01%	263
2019 Q4	$2K	Hold	24	–	–	﹤0.01%	337
2019 Q3	$2K	Buy	24 +4	+20%	+$332	﹤0.01%	371
2019 Q2	$2K	Sell	20 -4,805	-100%	-$410K	﹤0.01%	283
2019 Q1	$437K	Buy	4,825 +151	+3%	+$12.8K	0.11%	110
2018 Q4	$335K	Buy	4,674 +299	+7%	+$24.1K	0.1%	124
2018 Q3	$419K	Buy	4,375 +167	+4%	+$16.2K	0.11%	108
2018 Q2	$401K	Buy	4,208 +46	+1%	+$4.23K	0.12%	110
2018 Q1	$365K	Buy	4,162 +221	+6%	+$20.2K	0.12%	114
2017 Q4	$334K	Sell	3,941 -3,109	-44%	-$260K	0.11%	108
2017 Q3	$610K	Buy	7,050 +509	+8%	+$40.8K	0.22%	92
2017 Q2	$505K	Buy	6,541 +118	+2%	+$8.37K	0.2%	108
2017 Q1	$445K	Sell	6,423 -440	-6%	-$29.6K	0.18%	104
2016 Q4	$406K	Sell	6,863 -67	-1%	-$4.14K	0.19%	103
2016 Q3	$460K	Buy	6,930 +752	+12%	+$46.5K	0.23%	105
2016 Q2	$334K	Buy	+6,178	New	+$338K	0.17%	109